Whatever you may call it – scandal, conspiracy, scam, or deal – the Dengvaxia controversy must be fully investigated until it finds satisfactory closure.
The investigation or inquiry will be best carried out by the Department of Justice (DoJ), in collaboration with the National Bureau of Investigation (NBI).
For very sound reasons, a DoJ-NBI inquiry into Dengvaxia is infinitely preferable to a congressional inquiry into the matter, as some senators are contemplating.
The Dengvaxia alarm was triggered by a statement from Sanofi Pasteur that its immunization vaccine might have “severe” effects on those without a dengue history.
The less there is of this interference, the better for the Dengvaxia investigation.